+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amniotic Membrane for Ophthalmology Market - Global Forecast 2026-2032- Product Image
Amniotic Membrane for Ophthalmology Market - Global Forecast 2026-2032- Product Image
Sale

Amniotic Membrane for Ophthalmology Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6147364
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Amniotic Membrane for Ophthalmology Market is projected to reach USD 443.13 Million in 2026. It is expected to continue growing at a CAGR of 5.44%, reaching USD 606.57 Million by 2032.

Amniotic Membrane for Ophthalmology: Executive Overview

Amniotic membrane products are used in ophthalmology as biologic materials for ocular surface reconstruction, wound coverage, and management of selected corneal and conjunctival disorders. Their clinical value is linked to properties such as anti-inflammatory activity, epithelial support, and a physical barrier function. Adoption depends on clinical evidence, tissue-processing standards, reimbursement, surgeon familiarity, and the availability of appropriately screened and preserved tissue.

Clinical Integration Is Reshaping Ocular Surface Care

The field is moving toward more standardized patient selection, improved preservation and handling, and closer integration with corneal, refractive, emergency, and ocular-surface services. Clinicians increasingly evaluate amniotic membrane alongside established therapies, including lubricants, pharmaceutical treatment, sutures, contact-based devices, and surgical reconstruction. Regulatory oversight, traceability, sterility assurance, and consistent documentation remain central to broader clinical integration.

Artificial Intelligence Strengthens Selection, Documentation, and Follow-Up

Artificial intelligence can support ophthalmic imaging analysis, classification of epithelial defects, documentation of wound progression, and identification of patients who may benefit from advanced ocular-surface interventions. Its practical contribution is currently strongest as a decision-support and workflow tool rather than as a replacement for clinical judgment. Safe adoption requires representative datasets, transparent validation, privacy safeguards, and prospective assessment of whether algorithmic support improves outcomes or reduces avoidable variation.

Regional Insights: Regulation and Clinical Capacity Shape Adoption

North America is characterized by advanced corneal and ocular-surface services, established tissue-bank infrastructure, and close attention to regulatory and reimbursement requirements. Europe combines specialized ophthalmic centers with diverse national health systems, while European Union coordination supports common regulatory principles but does not eliminate country-level differences. Asia-Pacific includes highly developed ophthalmic systems alongside rapidly expanding specialist capacity, with access and tissue-processing infrastructure varying substantially. Latin America is supported by growing surgical expertise but faces uneven reimbursement, referral pathways, and tissue availability. The Middle East is strengthening tertiary ophthalmology services, particularly in major urban centers, while GCC countries often benefit from concentrated investment and cross-border specialist care. Africa presents significant unmet need and promising clinical-development opportunities, but access is constrained by workforce distribution, infrastructure, procurement, and continuity-of-care challenges.

Group Insights: Diverse Health-System Conditions Require Local Strategies

ASEAN markets reflect substantial differences in regulatory maturity, specialist density, hospital capability, and public-versus-private delivery. BRICS countries combine large and diverse patient populations with varied tissue-bank capacity, reimbursement structures, and clinical guidelines. The European Union benefits from shared scientific and regulatory dialogue, although implementation and funding remain nationally determined. G7 systems generally possess strong research, specialist, and quality-assurance capabilities, but face scrutiny over evidence, cost-effectiveness, and equitable access. NATO members span mature and developing ophthalmic infrastructures, making procurement resilience, emergency preparedness, and interoperable clinical standards relevant. GCC systems typically emphasize high-quality tertiary care, international collaboration, and investment in advanced ophthalmology.

Country Insights: Capacity and Policy Differences Define Market Conditions

Australia combines advanced ophthalmic practice with geographically dispersed populations that can complicate access outside major centers. Brazil has substantial clinical expertise but experiences regional differences in public-sector capacity and tissue availability. Canada has strong specialist services and research networks, alongside geographic access challenges. China is expanding ophthalmic capability and tissue-processing infrastructure while maintaining complex regulatory and regional implementation requirements. France, Germany, Italy, and Spain offer established European clinical systems, with differences in reimbursement, procurement, and hospital adoption. India combines high clinical demand and specialist innovation with uneven access between urban and rural settings. Japan and South Korea have sophisticated ophthalmology services and strong technology adoption, while Australia, Canada, and the United Kingdom continue to emphasize evidence, quality, and coordinated care. Mexico is developing specialist capacity amid access and reimbursement variation. Russia’s ophthalmic services and supply conditions are influenced by regional disparities, regulatory requirements, and broader healthcare constraints. The United States has extensive subspecialty capacity and tissue-bank experience, with adoption shaped by clinical evidence, payer policy, and institutional protocols.

Priorities for Industry Leaders: Evidence, Quality, and Access

Leaders should prioritize robust evidence packages that define appropriate indications, comparative clinical value, handling requirements, and patient-selection criteria. Quality systems should cover donor screening, processing, preservation, sterility assurance, traceability, and post-market surveillance. Partnerships with corneal specialists, tissue banks, hospitals, and professional societies can improve education and implementation. Commercial and access strategies should be adapted to national reimbursement and procurement systems rather than treated as globally uniform. Organizations should also invest in clinician training, standardized outcome measures, digital follow-up, and carefully governed artificial-intelligence tools that enhance documentation without weakening accountability.

Research Methodology: Evidence-Led Assessment of Clinical Adoption

The assessment should triangulate peer-reviewed ophthalmology literature, clinical guidelines, regulatory documents, tissue-bank standards, reimbursement policies, hospital protocols, and publicly available health-system data. Findings should be organized by indication, care setting, product format, preservation approach, regulatory pathway, and geography. Regional, group, and country comparisons should distinguish documented clinical practice from emerging use and should explicitly record differences in evidence quality, access, and implementation. Artificial-intelligence considerations should be evaluated through published validation, workflow relevance, governance, and patient-safety criteria. No unsupported market estimates, forecasts, or company-specific claims are used.

Conclusion: Responsible Integration Can Expand Ocular-Surface Care

Amniotic membrane remains a clinically relevant option for selected ophthalmic applications, particularly where ocular-surface healing, inflammation control, or tissue coverage is important. Its continued integration will depend less on availability alone than on reliable quality systems, clearer evidence, appropriate patient selection, trained clinicians, and equitable access. Regional and country-level differences require implementation strategies tailored to local regulation, infrastructure, reimbursement, and referral pathways. Used alongside established therapies and supported by disciplined evidence generation, the technology can contribute to more consistent ocular-surface management.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Amniotic Membrane for Ophthalmology Market, by Product Type
7.1. Introduction
7.2. Multi Layer Membrane
7.3. Single Layer Membrane
8. Amniotic Membrane for Ophthalmology Market, by Preservation Method
8.1. Introduction
8.2. Cryopreservation
8.3. Dehydration
8.4. Freeze Drying
8.5. Gamma Irradiation
9. Amniotic Membrane for Ophthalmology Market, by Distribution Channel
9.1. Introduction
9.2. Direct Sales
9.3. Distributors
9.4. Online
9.5. Retail Pharmacy
10. Amniotic Membrane for Ophthalmology Market, by Application
10.1. Introduction
10.2. Corneal Ulcer Treatment
10.3. Dry Eye Management
10.4. Glaucoma Surgery
10.5. Ocular Surface Reconstruction
10.5.1. Conjunctival Reconstruction
10.5.2. Limbal Stem Cell Deficiency
10.6. Pterygium Surgery
11. Amniotic Membrane for Ophthalmology Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Eye Clinics
11.4. Hospitals
12. Amniotic Membrane for Ophthalmology Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Amniotic Membrane for Ophthalmology Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Amniotic Membrane for Ophthalmology Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Amnio Technology LLC
16.2. Applied Biologics LLC
16.3. BioTissue Inc.
16.4. Celularity Inc.
16.5. Corza Ophthalmology
16.6. Derma Sciences Inc.
16.7. FzioMed Inc.
16.8. Human Regenerative Technologies LLC
16.9. Integra LifeSciences Holdings Corporation
16.10. IOP Ophthalmics
16.11. Labtician Ophthalmics Inc.
16.12. LifeCell International Pvt. Ltd.
16.13. Merakris Therapeutics Inc.
16.14. MiMedx Group Inc.
16.15. NuVision Biotherapies LLC
16.16. Organogenesis Holdings Inc.
16.17. Osiris Therapeutics Inc.
16.18. Skye Biologics Inc.
16.19. Smith & Nephew plc
16.20. Surgenex
16.21. Thea Pharma Inc.
16.22. TissueTech Inc.
16.23. VIVEX Biologics Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Amniotic Membrane for Ophthalmology Market, Years Considered for the Study
FIGURE 2. Global Amniotic Membrane for Ophthalmology Market, Research Design
FIGURE 3. Global Amniotic Membrane for Ophthalmology Market, Research Framework
FIGURE 4. Global Amniotic Membrane for Ophthalmology Market, Data Triangulation
FIGURE 5. Global Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2025 vs 2032 (%)
FIGURE 9. Global Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Amniotic Membrane for Ophthalmology Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Amniotic Membrane for Ophthalmology Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Amniotic Membrane for Ophthalmology Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Amniotic Membrane for Ophthalmology Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Amniotic Membrane for Ophthalmology Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Amniotic Membrane for Ophthalmology Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Amniotic Membrane for Ophthalmology Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Amniotic Membrane for Ophthalmology Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Amniotic Membrane for Ophthalmology Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Amniotic Membrane for Ophthalmology Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Amniotic Membrane for Ophthalmology Market Segmentation & Coverage
TABLE 2. Global Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 3. Global Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Multi Layer Membrane Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Multi Layer Membrane Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Multi Layer Membrane Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Single Layer Membrane Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Single Layer Membrane Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Single Layer Membrane Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 11. Global Cryopreservation Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Cryopreservation Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Cryopreservation Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Dehydration Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Dehydration Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Dehydration Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Freeze Drying Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Freeze Drying Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Freeze Drying Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Gamma Irradiation Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Gamma Irradiation Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Gamma Irradiation Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 24. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 37. Global Corneal Ulcer Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Corneal Ulcer Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Corneal Ulcer Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Dry Eye Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Dry Eye Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Dry Eye Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Glaucoma Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Glaucoma Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Glaucoma Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Ocular Surface Reconstruction Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Ocular Surface Reconstruction Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Ocular Surface Reconstruction Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Conjunctival Reconstruction Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Conjunctival Reconstruction Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Conjunctival Reconstruction Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Limbal Stem Cell Deficiency Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Limbal Stem Cell Deficiency Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Limbal Stem Cell Deficiency Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Pterygium Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Pterygium Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Pterygium Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Eye Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Eye Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Eye Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Amniotic Membrane for Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Amniotic Membrane for Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. North America Amniotic Membrane for Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. North America Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 78. North America Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 79. North America Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. North America Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. North America Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 82. North America Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Latin America Amniotic Membrane for Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Latin America Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 85. Latin America Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 86. Latin America Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 87. Latin America Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Latin America Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 89. Latin America Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Europe Amniotic Membrane for Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Europe Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. Europe Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 93. Europe Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 94. Europe Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Europe Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 96. Europe Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Middle East Amniotic Membrane for Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Middle East Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Middle East Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 100. Middle East Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. Middle East Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. Middle East Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 103. Middle East Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Africa Amniotic Membrane for Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Africa Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. Africa Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 107. Africa Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. Africa Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Africa Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 110. Africa Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Global Amniotic Membrane for Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. ASEAN Amniotic Membrane for Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. ASEAN Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. ASEAN Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 115. ASEAN Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. ASEAN Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. ASEAN Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 118. ASEAN Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. GCC Amniotic Membrane for Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. GCC Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. GCC Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 122. GCC Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. GCC Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. GCC Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 125. GCC Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. European Union Amniotic Membrane for Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. European Union Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. European Union Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 129. European Union Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. European Union Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. European Union Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 132. European Union Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. BRICS Amniotic Membrane for Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. BRICS Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. BRICS Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 136. BRICS Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. BRICS Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. BRICS Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 139. BRICS Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. G7 Amniotic Membrane for Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. G7 Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. G7 Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 143. G7 Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 144. G7 Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. G7 Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 146. G7 Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. NATO Amniotic Membrane for Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. NATO Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. NATO Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 150. NATO Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. NATO Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. NATO Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 153. NATO Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Global Amniotic Membrane for Ophthalmology Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. United States Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 156. United States Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. United States Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 158. United States Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. United States Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. United States Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 161. United States Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Canada Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 163. Canada Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. Canada Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 165. Canada Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. Canada Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. Canada Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 168. Canada Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Mexico Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 170. Mexico Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. Mexico Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 172. Mexico Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. Mexico Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Mexico Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 175. Mexico Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Brazil Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 177. Brazil Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. Brazil Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 179. Brazil Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. Brazil Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Brazil Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 182. Brazil Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. United Kingdom Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 184. United Kingdom Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. United Kingdom Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 186. United Kingdom Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. United Kingdom Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. United Kingdom Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 189. United Kingdom Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Germany Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 191. Germany Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. Germany Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 193. Germany Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. Germany Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Germany Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 196. Germany Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. France Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 198. France Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. France Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 200. France Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. France Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. France Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 203. France Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Russia Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 205. Russia Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. Russia Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 207. Russia Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Russia Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Russia Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 210. Russia Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Italy Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 212. Italy Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 213. Italy Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 214. Italy Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. Italy Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Italy Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 217. Italy Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Spain Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 219. Spain Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 220. Spain Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 221. Spain Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. Spain Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. Spain Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 224. Spain Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. China Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 226. China Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. China Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 228. China Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 229. China Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. China Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 231. China Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. India Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 233. India Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. India Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 235. India Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. India Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. India Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 238. India Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. Japan Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 240. Japan Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. Japan Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 242. Japan Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. Japan Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Japan Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 245. Japan Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Australia Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 247. Australia Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. Australia Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 249. Australia Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. Australia Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. Australia Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 252. Australia Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. South Korea Amniotic Membrane for Ophthalmology Market Size, 2017-2032 (USD Million)
TABLE 254. South Korea Amniotic Membrane for Ophthalmology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. South Korea Amniotic Membrane for Ophthalmology Market Size, by Preservation Method, 2017-2032 (USD Million)
TABLE 256. South Korea Amniotic Membrane for Ophthalmology Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. South Korea Amniotic Membrane for Ophthalmology Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. South Korea Amniotic Membrane for Ophthalmology Market Size, by Ocular Surface Reconstruction, 2017-2032 (USD Million)
TABLE 259. South Korea Amniotic Membrane for Ophthalmology Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Global Amniotic Membrane for Ophthalmology Market Share, by Key Player, 2025
TABLE 261. Global Amniotic Membrane for Ophthalmology Market, Key Experts

Companies Mentioned

  • Amnio Technology LLC
  • Applied Biologics LLC
  • BioTissue Inc.
  • Celularity Inc.
  • Corza Ophthalmology
  • Derma Sciences Inc.
  • FzioMed Inc.
  • Human Regenerative Technologies LLC
  • Integra LifeSciences Holdings Corporation
  • IOP Ophthalmics
  • Labtician Ophthalmics Inc.
  • LifeCell International Pvt. Ltd.
  • Merakris Therapeutics Inc.
  • MiMedx Group Inc.
  • NuVision Biotherapies LLC
  • Organogenesis Holdings Inc.
  • Osiris Therapeutics Inc.
  • Skye Biologics Inc.
  • Smith & Nephew plc
  • Surgenex
  • Thea Pharma Inc.
  • TissueTech Inc.
  • VIVEX Biologics Inc.

Related Topics

Related Reports

Amniotic Membrane Market - Global Forecast 2026-2032 - Product Image

Amniotic Membrane Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Global Amniotic Membrane Market Report by Product, Application, End User, Country and Company Analysis 2026-2034 - Product Image

Global Amniotic Membrane Market Report by Product, Application, End User, Country and Company Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
Amniotic Membrane - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Amniotic Membrane - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 117 Pages
  • Global
From
Amniotic Membrane Market Report 2026 - Product Image

Amniotic Membrane Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Amniotic Membrane Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 - Product Image

Amniotic Membrane Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034

  • Report
  • 138 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.